Strange India All Strange Things About India and world


Syphilis cases have risen by 52% since 2016 in the United States, but self-testing at home or anywhere for this sexually transmitted disease has not yet received approval by the US Food and Drug Administration (FDA; see Nature 605, 598–599; 2022). This puts US programmes implementing such tests, their associated laboratories, and online outlets at risk of regulatory non-compliance. It is creating confusion for patients and providers, whose requests for technical assistance and clarification are putting extra pressure on already-stretched public-health agencies. Moreover, the American Sexually Transmitted Diseases Association has issued a position statement that expresses concerns about the quality of available direct-to-consumer testing services in the absence of formal regulatory approval (C. Exten et al. Sex. Transm. Dis. 48, e155–e159; 2021).

The views are those of the correspondents and do not necessarily reflect the CDC’s position.

Competing Interests

Table of Contents

The authors declare no competing interests.



Source link

By AUTHOR

Leave a Reply

Your email address will not be published. Required fields are marked *